Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1166.0000 -6.70 (-0.57%)
NSE Jan 19, 2026 10:28 AM
Volume: 155.9K
 

logo
Aurobindo Pharma Ltd.
28 May 2024
1166.00
-0.57%
buy
by BOB Capital Markets Ltd.
Target: 1200
BOB Capital Markets Ltd.
ARBP: Strong quarter; OAI at Eugia-III an overhang. CPBI: In-line quarter; weak near-term outlook
 
Aurobindo Pharma Ltd. is trading below its 30 day SMA of 1197.4
More from Aurobindo Pharma Ltd.
Recommended
Market opens lower, Reliance Industries' Q3FY26 revenue jumps 10.5% YoY
Trendlyne Marketwatch | 19 Jan 2026, 10:07AM
Five Interesting Stocks Today - January 16, 2026
The Baseline | 16 Jan 2026
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020